FAYETTEVILLE, Ark., March 5, 2026 — HTA and Venture Atlas Labs announced a new commercial and clinical acceleration program that connects international health technology companies with leading U.S. clinical partners, evidence-generation opportunities, and strategic market entry pathways. Applications for its inaugural Rural Health Program will open soon.

HealthTech Bridge combines clinical engagement with practical commercialization guidance to help emerging healthtech companies successfully navigate the complex U.S. healthcare landscape. Unlike traditional accelerators, HealthTech Bridge is built specifically for the needs of international scaleups, offering structured clinical validation opportunities, including pilot studies and real-world clinical evaluations with provider partners, alongside commercialization strategy, reimbursement planning, investor readiness, and go-to-market support.

“For international healthtech companies, entering the U.S. market isn’t just about scaling what already works. It requires rethinking commercialization from the ground up. The U.S. healthcare system is complex, opaque, and often unforgiving to business models designed elsewhere,” said Elizabeth Jennings, Managing Partner of Venture Atlas Labs. “Through HealthTech Bridge, we’re helping founders pressure-test their strategy in real time, so they can enter the market with confidence and clarity.”

“Clinical evidence is a linchpin for success in healthcare innovation,” said Jeff Stinson, Director of HTA. “HealthTech Bridge is designed to help international founders not just understand the U.S. market, but generate the clinical proof and provider partnerships that accelerate adoption, reimbursement, and investor confidence.”

HealthTech Bridge builds on HTA’s nearly decade-long track record of facilitating real-world clinical partnerships and research collaborations. HTA’s accelerator ecosystem, including its flagship HeartX program, has historically guaranteed clinical pilots and studies for participants by working directly with hospitals and health systems that choose and sponsor cohort companies.

The first cohort launching through HealthTech Bridge — the Rural Health Program — will soon begin accepting applications. This program will connect innovations that focus on improving cardiometabolic health with rural healthcare providers, community partners, and clinicians working to close gaps in access, outcomes, and care delivery for underserved populations. Rural communities face particularly stubborn challenges, including workforce shortages, infrastructure limitations, and limited access to care.

The Rural Health Program aims to facilitate clinical evaluations and pilot implementations in rural settings, enabling companies to generate evidence in environments where healthtech solutions can make a measurable difference. Participating organizations will gain early access to real-world data and feedback that can inform product development, deployment strategies, and future commercial relationships.

HealthTech Bridge is tailored for startups and scaleups that have demonstrated traction outside the United States but need support with the clinical, regulatory, and commercial complexities of the U.S. healthcare market. The program offers a structured international-focused curriculum, mentorship from proven health care leaders, facilitated clinical studies with U.S. provider organizations, and introductions to investors. Learn more at healthtechbridge.com.

ABOUT HTA
HTA helps drive innovation for healthcare provider organizations through its accelerator programs and internal innovation initiatives. Its flagship accelerator, HeartX, recruits from around the world to support the most accomplished cardiovascular-focused startups in digital health, medical devices, and diagnostic platforms. Companies accepted into the program are guaranteed at least one pilot project or clinical trial with one of the ten largest hospitals and health systems in Arkansas. More information is available at HTA.health.

ABOUT VENTURE ATLAS LABS
Venture Atlas Labs helps international healthcare innovators scale into the U.S. and throughout Europe. By partnering with innovation hubs and investors around the world, Venture Atlas Labs guides commercialization via health economics in 28 countries, regulatory and quality risk structuring, and strategic advice. Their healthcare commercialization workshops are incorporated into clusters, accelerators, and conference programming throughout Europe. Learn more at ventureatlaslabs.com.

For more information, contact:

Jeff Stinson
+1.501.766.0633
[email protected]

Elizabeth Jennings
[email protected]

SOURCE HealthTech Bridge

Backed by Andreessen Horowitz, the AI-native company is redefining procurement with a virtual workforce that executes purchasing end-to-end

NEW YORK, March 5, 2026 — Lio (formerly known as askLio), the company building an agentic AI platform for enterprise procurement, today announced a $30 million Series A funding round led by Andreessen Horowitz (a16z), with participation from SV Angels, Harry Stebbings and Y Combinator. The new capital brings Lio’s total funding to $33 million and will be used to accelerate product development and support its expansion into the U.S.

Procurement is one of the largest spend categories in the enterprise, yet it still runs like an administrative back-office function. Enterprises spend over $180 billion annually on procurement talent, compared to roughly $10 billion on procurement software, reflecting how much work still happens manually around existing systems. Workflows remain slow and manual, with requests moving through layers of systems, rules, and approvals. Even with heavy investment in eProcurement software, decisions still happen at human speed – forcing teams to scale headcount or outsource work, often at up to 20x the cost of software.

Lio addresses this challenge by introducing Agent Operating Procedures (AOPs) to procurement – a shift enabled by recent advances in AI that make autonomous execution of complex enterprise workflows possible for the first time.

Rather than adding another layer of procurement software, Lio provides enterprises with a virtual, agentic procurement department. Its agents operate as a procurement workforce, executing the same standard operating procedures as experienced buyers, shared service centers, or outsourced BPOs, but at machine speed and scale. The agents triage requests, analyze quotes, compare suppliers, negotiate, onboard vendors, and execute purchases end-to-end across ERPs, systems of record, inboxes, contracts, and the open web. This represents a fundamentally new approach to back-office operations, challenging the long-standing assumption that procurement work must scale with headcount.

Rather than simply moving tasks between systems, Lio’s agents do the work itself – replacing fragmented workflows and expensive human review with intelligent automation that frees procurement teams to focus on strategy, compliance, and savings.

“The procurement organization of the future will look fundamentally different from today,” 

said Vlad Keil, founder and CEO of Lio.

“Teams won’t scale through headcount or more tools, but through AI agents that execute work end-to-end. Procurement teams will shift from doing manual work to directing and supervising an AI workforce. Lio was built to create virtual buyers that work alongside human teams, together shaping the procurement workforce of the future.”

Since launching in 2023, Lio’s agents have managed billions of dollars in enterprise spend and are used by dozens of Global 2000 and Fortune 500 companies worldwide. Customers include Munich Re, the world’s largest reinsurer; Brose, among the largest family-owned automotive suppliers globally; and Novozymes, a global leader in biological solutions — alongside enterprises across chemicals, postal services, retail, transportation, medical technology, and pharmaceuticals.

“Leading organizations are transitioning to AI augmented procurement operating models, and they are doing so quickly. Agentic AI systems for procurement, such as Lio, will be pivotal in that shift. What sets Lio apart is the level of innovation and creativity its founder has applied to solving one of the hardest challenges in this space: serving the enterprise customer. They are reimagining how procurement can operate in a wide range of environments and the technology is fundamentally different from anything I have used in my career. The impact is real, and the ROI is compressed from years to weeks,”

said Jared Petras, Senior Director of Global Procurement Digital Transformation at Walmart.

“In collaboration with Lio, we are redefining the future of Purchasing at Schaeffler. The rapid progress and measurable outcomes underscore the transformative potential of agentic AI. This collaboration strengthens our AI-driven capabilities, increases efficiency at scale, and underlines our ambition to be a pioneer in innovation and operational excellence.”

said Andreas Schick, COO at Schaeffler, one of the world’s largest automotive and industrial suppliers.

Customers using Lio report:

• Over 95% adoption rates, delivering a consumer-grade purchasing experience with just a few clicks
• 85% less manual work, eliminating the need to outsource large portions of procurement operations
• 10% incremental savings, driven by better sourcing, negotiation, and real-time optimization
• 100% customer retention, fueled by rapid deployment and measurable results

In one example, a global tier-1 industrial manufacturer automated 75% of previously outsourced procurement work in six months, freeing the equivalent of 10 full-time employees.

“We’re entering a phase in the enterprise where AI moves beyond workflow co-pilots to autonomous, multi-agent execution,”

said Seema Amble, Partner at Andreessen Horowitz.

“Lio is applying that shift to procurement – one of the largest and most operationally complex functions in the enterprise.”

About Lio
Lio (formerly known as askLio) builds the world’s most advanced AI procurement workforce for enterprise companies worldwide. Every purchase request is managed by specialized agents working in parallel – researching vendors, negotiating terms, managing approvals, and tracking deliveries simultaneously. What once consumed your team’s hours is now executed by a coordinated network of AI Agents. Learn more at lio.ai.

About Andreessen Horowitz
Andreessen Horowitz (aka a16z) is a venture capital firm that backs bold entrepreneurs building the future through technology. We are stage agnostic: We invest in seed to venture to growth-stage technology companies, across bio + healthcare, consumer and enterprise apps, crypto, fintech, infrastructure, and companies building toward American dynamism. a16z has over $90B under management across multiple funds.

CONTACT: Jill Staebe, Head of Marketing – [email protected]

Video – https://mma.prnewswire.com/media/2927062/Lio_Technologies_Video.mp4
Logo – https://mma.prnewswire.com/media/2927055/Lio_Technologies_Logo.jpg

SOURCE Lio Technologies GmbH

HERZLIYA, Israel, March 5, 2026 — Vintage Investment Partners (“Vintage”), a global venture capital platform with $4.4 billion in AUM and founded in 2003, today announced that David Chiodo has joined Vintage’s investment team. Based in New York, David will further deepen Vintage’s commitment to, and engagement with, VC fund managers, founders, and the broader venture ecosystem in the U.S. & Canada.

Vintage has been an active investor in the North American venture market for many years, backing leading venture funds and leading private tech companies, while facilitating cross-border investment and corporate innovation through its Fund of Funds, Growth, and Secondary investment strategies. Establishing a dedicated, on-the-ground presence in New York reflects the firm’s continued commitment to serving its partners across the U.S. and Canada.

David has a strong background in fund investments, venture secondaries, and value creation. Prior to joining Vintage, David was a Vice President at Sagard Private Equity Solutions (FKA Performance Equity Management), where he helped lead the firm’s emerging venture program. His focus included sourcing, evaluating, and managing VC fund commitments, along with executing GP-led, LP-led, and direct secondary transactions.

He previously served as a Senior Associate at EY-Parthenon in the Private Equity Value Creation practice, advising private equity clients on operational diligence, transaction execution, and portfolio strategy across technology, transportation, and industrial sectors. David holds a B.S. in Policy Analysis and Management from Cornell University and is the Co-Head of the NYC Chapter of the Emerging Allocators Association.

“I’m very excited to join Vintage and deepen the firm’s U.S. presence. Vintage is defined by its service-first culture and a highly connected global network, and I look forward to partnering with the leading venture capital fund, companies and LPs across the U.S. and Canada,” David shared.

“As we continue to build long-term partnerships across the U.S. and Canadian venture ecosystem, having a local presence will enhance our efforts tremendously. In particular, with David’s addition, we not only see significant opportunities to partner with leading emerging managers, but also increase our support of CEOs, founders and fund managers through tailored secondary solutions, while also participating in direct investments into breakout companies at the growth stage. David’s combination of experience, analytical rigor, and relationship-driven approach aligns with our values and global strategy,” said Asaf Horesh, Co-Managing Partner at Vintage.

“David’s background investing in leading fund managers, sourcing secondaries, and value creation well equips him to support our partners and identify exceptional opportunities across the market. We are very pleased to welcome him to Vintage and strengthen our presence in the U.S.,” added Abe Finkelstein, Co-Managing Partner at Vintage.

About Vintage Investment Partners

Founded in 2003, Vintage Investment Partners is a global venture capital platform managing more than $4.4 billion across Fund-of-Funds, Secondary, and Growth-Stage strategies in the U.S., Europe, Israel, and Canada. Vintage is invested in many of the world’s leading venture funds and growth-stage tech startups and has exposure directly and indirectly to over 7,400 technology companies. Through Value+, its free-of-charge platform connecting venture-backed startups with corporations seeking innovation, Vintage has facilitated more than 300 pilots, purchase orders, and paid proof-of-concepts, generating hundreds of millions of USD in revenue for startups.

Photo: https://mma.prnewswire.com/media/2926919/David_Chiodo_Vintage_Investment_Partners.jpg

SOURCE Vintage Investment Partners

• AgriPass Empowers Small and Mid-Sized Farmers to Transition to Sustainable, Regenerative Agriculture, reducing erosion, herbicides and supporting water conservation
• Replaces up to 20 manual workers in a day to focus on more strategic work 
• Designed for commercial deployment with affordable solution  

TEL AVIV, Israel, March 5, 2026 — AgriPass has completed a $7.5M seed funding round to accelerate the commercial scale-up of RHIC, its human-inspired robotic weed control platform, to expand across the United States and Europe.

RHIC (Robot of Human Inspired Cultivation) combines advanced computer vision with real-time contextual AI to guide selective mechanical actuation, targeting weeds at the root level while minimizing soil disruption and eliminating chemical dependency. 

The funding round was led by Harbor Venture Consulting, with support from existing investors includingE44 Climate Ventures, and strategic ecosystem partners. The funding will support manufacturing readiness, expansion of commercial field operations, and continued development of the AI-driven cultivation platform across additional crops and use cases.

Established in 2023, AgriPass already has active commercial deployments in both the EU and the U.S., with contracted and advanced-stage engagements contributing to projected 2026 revenue.  The platform empowers farmers, particularly small and mid-sized operations, in the transition to sustainable, and regenerative agriculture through adaptive, selective, non-chemical weed control that works at commercial scale. It is initially focused on high-value vegetable crops, where labor shortages, weed pressure, and soil health constraints most directly impact productivity and farm economics.

“Labor volatility, regulatory pressure, and soil degradation are redefining farm operations. Food security now depends on building more resilient production systems and agriculture is undergoing a structural transformation to meet these challenges,” said Liron Yanay, CEO of AgriPass. “We built RHIC to replicate human agronomic judgment in real time, guiding soil-safe, selective mechanical action at commercial scale. This funding enables us to expand across the U.S. and Europe and scale our durable cultivation platform designed for long-term performance.”

At its core, RHIC integrates contextual AI with mechanical actuation, guiding physical intervention based on weed presence, crop proximity, and soil conditions as work is performed. The platform adapts depth and engagement dynamically, delivering human-like selectivity at industrial scale.

AgriPass collaborates with partners across the ag-robotics and food-system ecosystem, including FYELD Agriculture OEM, EIT Food, and the NVIDIA Inception Program, supporting both technology development and field deployment. The company was recently named a winner of the 2025 Climate Solutions Prize, and CEO Liron Yanay was recognized as a leading Woman in AgFood 2025.

Live updates and demonstrations will be shared at the World Agri-Tech Innovation Summit in San Francisco, March 16–18, 2026.

About AgriPass

AgriPass Robotics is an AI and Robotics company specializing in human-inspired AI for adaptive field operations in agriculture. The company develops real-time AI decision-making technology that enables agricultural machinery to interpret agronomic context and dynamically adjust operational decisions. Its RHIC (Robotic Human-Inspired Cultivation) platform translates human field decision-making into machine action, supporting farmers in addressing labor shortages while maintaining sustainable, stable and efficient operations.

Media Contact:
Nicole Conley
[email protected]

SOURCE AgriPass

The end-to-end platform validates demand, executes growth, and finances scale for direct-to-consumer brands; ZyG raises $58M seed round

Tel Aviv, ISRAEL, March 5, 2026 — ZyG today announced the launch of its Agentic Operating System, an end-to-end platform redefining how direct-to-consumer (DTC) products become brands. In an eCommerce market where 90% of new product launches never reach scale, success demands far more than a great product. It requires integrated execution across marketing, data, and capital, which product innovators and DTC brands simply don’t have access to. Until now. The ZyG platform validates scale potential before launch, executes every stage of the customer lifecycle, and removes much of the financing risk involved in scaling a DTC brand.

Built by ironSource founders alongside world-class experts in AI, growth, and eCommerce, ZyG has raised a $58M seed round from leading investors, including Bessemer Venture Partners, Viola Ventures, and Lightspeed Venture Partners, with participation from Disruptive AI, Emerge, Access Industries, Stardom Ventures, and Jibe Ventures.

“Today, product innovators are set up to fail. You can build an incredible product and website, but still have no viable path to becoming a brand that reaches $100M+ in annual sales. Most DTC products stall because founders are forced to master growth marketing, data science, and capital strategy, all at once. That’s unrealistic,” said Omer Kaplan, Co-Founder and CEO of ZyG. “ZyG exists to change that equation. We’re building a new partnership model that lets founders focus on what they do best – creating amazing products – while our data, technology, AI agents, and financing, power the product to scale.”

A New Partnership Model

ZyG works with product innovators, entrepreneurs, and DTC brands, offering an innovative business model that is completely aligned with its partners.

Products whose scale potential is validated, reaching a strong ‘ZyG Score’ on the proprietary Agentic Marketability Test, can partner with ZyG, which executes the entire digital layer and supports operational scale, saving partners both the time and the costs of growing headcount, agencies and tools.

The business model is a simple pay-as-you-grow consumption fee and the partners maintain full control of their brand IP and recognize 100% of revenue generated.

ZyG also offers products with a high ZyG Score cohort financing based on its proprietary models, addressing the inherent challenges DTC products face in financing growth, especially for LTV-driven products where customer acquisition costs are recouped over time.

“It is very clear what product innovators and DTC brands don’t need: more software, more agencies, or higher headcount,” said Kaplan. “What ZyG is offering is an Operating System that executes every aspect of growth, allowing partners to focus on product innovation while preserving their equity.” 

A New Infrastructure for eCom Scale

At the heart of the ZyG Operating System is a unified data layer that transforms disparate sources – pixels, platforms, and the many specialized tools used in DTC growth – into a single source of truth across the user journey.

This data foundation is critical to building a strong, trustworthy network of AI Agents that can execute the entire digital layer from brand optimization to store building, creative generation, performance marketing, organic growth (SEO, GEO, and influencers), conversion, retention (customer support and email/SMS), to logistics optimization. The connectivity and collaboration between the Agents, built on a shared context, allow signals from any point in the customer journey to continuously inform and improve the entire system.

The data layer is also the basis for proprietary predictive models that optimize growth, including LTV forecasting, attribution and cohort analysis, churn prediction, pricing optimization, and inventory demand forecasting.

The result is a compounding intelligence loop where every signal strengthens the models and drives smarter growth decisions.

About ZyG

ZyG is an Operating System for eCom scale, turning great products into successful brands. ZyG’s platform is designed to help product inventors and DTC brands validate, scale, and finance their growth, powered by data-driven AI agents. For more information, visit www.zyg.com or contact [email protected].

Logo – https://mma.prnewswire.com/media/2925884/5835940/ZyG_Logo_Logo.jpg

SOURCE ZyG

Final close of Galvanize Real Estate Fund I includes investments from range of pension funds, banks, foundations, and other leading international institutions

NEW YORK, March 5, 2026 — Galvanize, a global asset manager investing at the intersection of energy innovation, resilience, and intelligence, today announced the final close of its Galvanize Real Estate Fund I (“the Strategy”). With $370 million in commitments from a globally diverse set of institutional investors, including pension funds and foundations, RIAs, banks and their clients, and family offices, the strategy is advancing the application of decarbonization as a core driver of value creation.

Galvanize Real Estate (GRE) targets undercapitalized commercial buildings in supply-constrained, high growth U.S. markets that represent attractive opportunities to drive net operating income (NOI) growth, through the implementation of its profitable decarbonization strategy. Against the backdrop of accelerating load growth and rising electricity rates, real estate owners and tenants are demanding more control over energy. GRE’s decarbonization and resilience interventions — which include a combination of on-site renewable energy generation, energy efficiency retrofits, and electrification — aim to protect against rising costs and reduce building emissions.

“GRE’s strategy demonstrates a different role for sustainability, one that places it at the center of profit generation and product differentiation,” said Katie Hall, Co-Chair & CEO, Galvanize. “In an environment where the combined impact of rising electricity prices and market volatility is accelerating, there is a large and ongoing opportunity for the team to leverage decarbonization as a driver of value creation.”

“We are honored by the confidence such a diverse set of investors has placed in the Galvanize Real Estate team,” noted Joseph Sumberg, Managing Partner & Head of Galvanize Real Estate. “As the cost, reliability and resilience of energy becomes increasingly salient for commercial real estate owners and tenants, I believe GRE’s profitable decarbonization strategy is well positioned to continue generating long-term value across our growing portfolio.”

GRE investment professionals collaborate with a team of in-house scientists, climate technologists, and policy experts who help to evaluate and seek to deliver on each property’s decarbonization potential. Additionally, a portion of GRE’s long-term economic incentives are tied to successfully achieving operational net-zero emissions in its portfolio within three years.

To date, the Fund has made five investments in 15 buildings across 11 U.S. cities, totaling 2.4 million square feet.¹ The team believes it can achieve portfolio-level decarbonization of 153% in its initial portfolio through its solar, electrification, and energy reduction efforts, leading to an estimated 8,224 metric tons of avoided emissions annually. The award-winning Galvanize Real Estate team is actively combining its expertise in energy with capital to upgrade existing properties, while pursuing disciplined acquisitions that represent a strategic fit.

About Galvanize
Galvanize is a global asset manager investing at the intersection of energy innovation, resilience, and intelligence. The firm deploys capital across seed, venture, growth, public equities, credit, and real estate, combining investment expertise with deep in-house capabilities in technology, policy, and markets. Galvanize is built to identify opportunities created by structural change in the 21st century economy and convert them into long-term value.

¹ As of December 2025.

SOURCE Galvanize

MOORPARK, Calif., March 5, 2026 — Aspire Broadband Holdings, Inc. dba Aspire Fiber is a Southern California-based internet service provider, delivering next-generation 10 Gbps fiber-to-the-home internet to consumers throughout Southern California and beyond. As part of this majority investment, Arenova Capital, a Dallas-based growth equity firm, has committed to invest $50 million of equity capital into Aspire to fuel the Company’s network expansion. Stephen Weatherford and the management team of Aspire Fiber remain as meaningful shareholders and will continue leading the business going forward.

Aspire Fiber launched its first service market in Moorpark, California late last year and is undergoing active construction in the remainder of Moorpark and nearby Santa Clarita. With its expanded backing, Aspire is actively evaluating and in discussions with additional expansion markets throughout California.

“This partnership with Arenova marks a significant milestone for our company,” said Stephen Weatherford, Chief Executive Officer of Aspire Fiber. “We share a long-term vision for building high-quality, community-focused fiber internet infrastructure across California. With Arenova’s strategic capital and deep domain expertise in fiber investing, we are well-positioned to accelerate our expansion while maintaining disciplined execution and operational excellence.”

“We are incredibly excited to partner with Stephen and the Aspire Fiber team at this important inflection point,” said David Li, Managing Partner of Arenova. “Although Aspire is still early in its lifecycle, Stephen and his team are extremely experienced in the fiber sector and we are highly aligned with Aspire’s mission of bringing next-generation fiber service to Californian consumers who currently lack access to symmetrical fiber-to-the-home internet. We believe Southern California represents a highly compelling opportunity for long-term fiber investment, and we look forward to supporting the Company’s continued growth.”

Aspire Fiber’s strategy emphasizes partnering with municipalities and local stakeholders to expand access to advanced broadband connectivity and support regional economic development. Aspire deploys a next-generation 10 Gbps fiber-to-the-home network, built primarily underground, to enhance resiliency, future-proof reliability, and community integration.

About Aspire Fiber

Aspire Fiber is a Southern California-based internet service provider delivering next-generation, 10 Gbps fiber-to-the-home internet across Ventura and Los Angeles Counties. The company is focused on building future-proof, scalable, high-performance broadband infrastructure designed to serve communities for decades to come.

About Arenova

Arenova Capital is a principal investment firm focused on founder-owned and founder-led companies in the middle market. Arenova seeks to catalyze growth in technology-enabled, media and communications companies through thoughtful partnership, support and investment, with the goal of building enduring industry leaders. Arenova Capital is based in Dallas, TX and was founded in 2022.

SOURCE Aspire Fiber, LLC

– NexCure founded by Raven, RA Capital’s healthcare incubator, to address capacity constraints and access challenges for lifesaving therapies –

– Financing led by RA Capital with participation from Cencora Ventures and Oncology Ventures –

BOSTON, March 5, 2026 — NexCure, Inc. today launched with a bold mission to address one of healthcare’s most pressing challenges: access to advanced, life-saving therapies for patients who need them most. By delivering CAR-T and other clinically intensive treatments in community-based outpatient settings, NexCure brings these therapies closer to home. The company is backed by a $19 million Series A financing led by RA Capital Management, with participation from Cencora Ventures and Oncology Ventures.

NexCure combines purpose-built outpatient clinics with proprietary technology designed to support the complexity of CAR-T and other advanced therapeutics. NexCure meets patients where they are by bringing clinically intensive therapies into outpatient settings and removing the geographic, financial, and logistical barriers that stand between patients and the care they need. The model expands access for patients, referring oncologists, health systems, payers, and manufacturers seeking reliable sites of care.

“I understand first hand the impact that cell therapy can deliver for people suffering from cancer and other diseases, and we are determined to surmount the operational barriers care providers face when attempting to provide access to these life-changing treatments,” said Sophie Papa, FRCP, PhD, Founder and Chief Medical Officer at NexCure. “NexCure is helping to solve the challenge of bringing current and future complex therapies, with high care and monitoring needs, to the patients that need them.”

The company was founded by Raven, RA Capital’s healthcare incubator, to address capacity constraints and access challenges for lifesaving therapies. Out of 6,100 hospitals in the US, only ~200 – just 3% – administer CAR-T therapy.

“Today, only a fraction of patients who are eligible for CAR-T therapy actually receive it, largely due to where and how care is delivered,” said Paul Rothman, MD, Venture Partner at Raven, RA Capital’s healthcare incubator, and Founder and Board Chair of NexCure. “As CAR-T matures and moves beyond oncology into autoimmune and other diseases,NexCure will work in partnership with the health ecosystem to thoughtfully expand access so more patients can receive advanced therapies in settings that are safe, effective and closer to home.”

The company’s proprietary platform standardizes protocols, automates care coordination, and reduces operational variability, enabling advanced therapies to be delivered beyond a small number of academic centers. This financing will support NexCure as it builds out the operating system for clinically intensive therapy delivery, integrating clinical decision support, remote monitoring, and operational intelligence.

“CAR-T and advanced oncology therapies are at a historic breakthrough moment, but the infrastructure to deliver them hasn’t kept pace,” said Ben Freeberg, Founder and Managing Partner of Oncology Ventures. “We are excited to invest in NexCure as they solve that bottleneck with a scalable outpatient clinic model that expands access, increases efficiency, and redefines where advanced therapeutics can be safely and efficiently delivered.”

NexCure is led by:

• Paul Rothman, MD, is NexCure’s founder and Board Chair and also a Venture Partner at Raven and former Dean of Johns Hopkins University School of Medicine and CEO of Johns Hopkins Medicine. Paul is a distinguished physician-executive known for building and leading world-class academic medical centers and translating innovation into patient care.
• Jennifer Smith, NexCure CEO, brings more than 20 years of healthcare operations experience focused on expanding access, scaling innovative clinical models, and building high-performing organizations.
• Sophie Papa, FRCP, PhD, is Co-founder & Chief Medical Officer of NexCure and an internationally recognized expert in cellular therapy, translating academic innovation into scalable, high-quality patient care.
• Anish More, Co-founder & Chief Business Officer of NexCure, brings extensive experience leading operations and strategy across high-growth healthcare organizations.

About NexCure

NexCure provides clinically intensive therapeutics in community, outpatient settings, redesigning how CAR-T and other advanced treatments are delivered, monitored, and scaled. NexCure translates hospital-grade clinical rigor into scalable, community-based outpatient clinics designed specifically for next-generation therapeutics. Its platform integrates AI-powered patient selection, remote monitoring, and standardized clinical protocols to ensure every patient receives safe, compassionate, and personalized treatment.

For more information about NexCure visit https://nexcure.com/.

About RA Capital Management

Founded in 2004, RA Capital Management is a multi-stage investment manager dedicated to evidence-based investing in public and private healthcare, life sciences, and planetary health companies. RA Capital creates and funds innovative companies, from private seed rounds to public follow-on financings, allowing management teams to drive value creation from inception through commercialization and beyond. RA Capital’s knowledge engine is guided by its dedicated, science-first internal research division and Raven, RA Capital’s healthcare incubator, offers entrepreneurs and innovators a collaborative and comprehensive platform to explore the novel and the re-imagined. RA Capital has more than 200 employees and over $14 billion in assets under management. Learn more at www.racap.com.

About Cencora Ventures

Cencora Ventures is the dedicated corporate venture capital fund of Cencora. Cencora is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. We partner with pharmaceutical innovators across the value chain to facilitate and optimize market access to therapies. Care providers depend on us for the secure, reliable delivery of pharmaceuticals, healthcare products, and solutions. Our 51,000+ worldwide team members contribute to positive health outcomes through the power of our purpose: We are united in our responsibility to create healthier futures. Cencora is ranked #10 on the Fortune 500 and #18 on the Global Fortune 500 with more than $300 billion in annual revenue. Cencora Ventures is managed in collaboration with Cerity Partners Ventures.

About Oncology Ventures

Oncology Ventures is a venture capital firm focused exclusively on advancing innovation in cancer care. The firm invests in commercially-validated start-ups transforming the future of cancer care through better data infrastructure, digital health solutions, and AI powered technologies. With deep expertise in the oncology ecosystem, Oncology Ventures partners with visionary founders to accelerate the transformation of cancer diagnosis, treatment, and care delivery worldwide.

SOURCE NexCure Inc.

Investment led by participation from the Al Nahyan family, Al-Ketbi family, and existing investor Pulsar Capital

DUBAI, UAE, March 5, 2026 — TruDoc Healthcare, the GCC’s premier virtual-first, full-stack healthcare platform, today announced the successful closure of a $15 million Pre-Series B funding round. The round saw significant participation from the Al Nahyan family and the Al-Ketbi family, alongside continued support from existing investor Pulsar Capital.

The investment reflects growing confidence in healthcare models that move beyond hospitals as physical destinations, toward systems that deliver continuous, clinical-grade care wherever patients are. TruDoc is using the capital to deepen its position as a single, accountable virtual first healthcare provider, while expanding what is already the largest at-home critical care deployment in the GCC. 

TruDoc is fundamentally re-architecting the patient journey, by combining virtual-first primary care, longitudinal chronic disease management, pharmacy-at-home, diagnostics, in-home services, and the region’s largest hospital-at-home critical care program, TruDoc delivers continuous care across the full lifecycle of a patient—not just moments of illness. The result is faster intervention, fewer hospital admissions, better adherence, and a single accountable care partner for patients, payors, and providers alike.

Reimagining Care: Beyond the Four Walls

This capital infusion signals a paradigm shift toward healthcare that follows the patient, not the facility. TruDoc is leveraging this investment to solidify its role as the GCC’s primary accountable care partner, scaling the region’s most sophisticated at-home critical care deployment.

By fusing virtual-first primary care with longitudinal disease management and hospital-grade home diagnostics, TruDoc is dismantling the region’s fragmented legacy systems. This ‘Care Operating System’ bypasses physical infrastructure bottlenecks, delivering 24/7 clinical interventions that improve adherence and keep patients out of high-cost hospital beds. From streamlining insurer costs to expanding governmental care capacity, TruDoc is turning healthcare into mission-critical virtual infrastructure that serves the UAE and Saudi Arabia at population scale.

Leadership Perspectives

Dr. Ahmed Mansour, CEO, Private Department of H.E. SH. Mohamed Bin Khaled Al Nahyan, said: “Healthcare systems everywhere are being asked to do more—serve more people, manage more chronic disease, and deliver better outcomes—without endlessly expanding physical infrastructure. TruDoc represents a fundamentally different approach: one that scales access and efficiency while maintaining clinical integrity. This model is well aligned with the UAE’s long-term priorities and the future of healthcare delivery across the Middle East. Believing in TruDoc model to lead this market innovation and increase the ultimate efficiency of the healthcare industry.”

Vish Narain, Executive Chairman at TruDoc, said: “For centuries, healthcare has been organised around buildings—patients moving toward facilities, systems optimised for episodic care. That architecture no longer reflects how people live, age, or manage chronic disease. What TruDoc is building is healthcare as infrastructure: continuous, accountable, and designed to operate beyond four walls, at population scale.”

Asad Khan, CEO at TruDoc, said: “The question is no longer whether high-quality care can be delivered outside hospitals—it’s how fast healthcare systems can adapt to that reality. TruDoc has shown that hospital-grade, high-acuity care can be delivered safely and effectively in homes, at scale. This capital allows us to expand that model across the GCC while staying relentlessly focused on clinical excellence and patient trust.”

About TruDoc:

TruDoc is the region’s largest virtual-first healthcare provider, dedicated to leading care beyond hospital walls. Headquartered in the UAE, TruDoc combines clinical excellence with technology to redefine healthcare for millions. By making virtual-first the standard, we empower individuals and governments with 24/7 telemedicine, wellness, and real-time care—anytime and anywhere.

About Private Department of H.E. SH. Mohamed Bin Khaled Al Nahyan: 

The Al Nahyan Family Office represents long-term strategic investments across healthcare, education, technology, and infrastructure, aligned with the UAE’s vision for sustainable economic and social development.

Mashreq Bank acted as an advisor to the transaction.

Experience healthcare that’s proactive, predictive, and personal.
This is the future—delivered today.

[email protected] | ☎ 800 878362
https://trudochealth.com

Photo: https://mma.prnewswire.com/media/2926772/TRUDOC_15Mn.jpg
Logo: https://mma.prnewswire.com/media/2926771/TruDoc_Logo.jpg

SOURCE Trudoc Health